These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 21725512

  • 1. Predictive factors for nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD).
    Fierbinteanu-Braticevici C, Baicus C, Tribus L, Papacocea R.
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):153-9. PubMed ID: 21725512
    [Abstract] [Full Text] [Related]

  • 2. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease.
    Palekar NA, Naus R, Larson SP, Ward J, Harrison SA.
    Liver Int; 2006 Mar; 26(2):151-6. PubMed ID: 16448452
    [Abstract] [Full Text] [Related]

  • 3. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S, Yukawa T, Uetake S, Yamauchi M.
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease.
    Miele L, Forgione A, La Torre G, Vero V, Cefalo C, Racco S, Vellone VG, Vecchio FM, Gasbarrini G, Rapaccini GL, Neuman MG, Grieco A.
    Transl Res; 2009 Oct; 154(4):194-201. PubMed ID: 19766963
    [Abstract] [Full Text] [Related]

  • 5. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
    Boza C, Riquelme A, Ibañez L, Duarte I, Norero E, Viviani P, Soza A, Fernandez JI, Raddatz A, Guzman S, Arrese M.
    Obes Surg; 2005 Sep; 15(8):1148-53. PubMed ID: 16197788
    [Abstract] [Full Text] [Related]

  • 6. Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients.
    Francque SM, Verrijken A, Mertens I, Hubens G, Van Marck E, Pelckmans P, Michielsen P, Van Gaal L.
    Clin Gastroenterol Hepatol; 2012 Oct; 10(10):1162-8; quiz e87. PubMed ID: 22796457
    [Abstract] [Full Text] [Related]

  • 7. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP, Xun YH, Hu CB, Zhang L, Liu H, Lou GQ, Fan JG.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [Abstract] [Full Text] [Related]

  • 8. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.
    Hossain N, Afendy A, Stepanova M, Nader F, Srishord M, Rafiq N, Goodman Z, Younossi Z.
    Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1224-9, 1229.e1-2. PubMed ID: 19559819
    [Abstract] [Full Text] [Related]

  • 9. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
    Angulo P, Keach JC, Batts KP, Lindor KD.
    Hepatology; 1999 Dec; 30(6):1356-62. PubMed ID: 10573511
    [Abstract] [Full Text] [Related]

  • 10. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M, George J.
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [Abstract] [Full Text] [Related]

  • 11. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS, Helzberg JH, Nachnani JS, Gurram K.
    Surg Obes Relat Dis; 2008 Dec; 4(5):612-7. PubMed ID: 18226970
    [Abstract] [Full Text] [Related]

  • 12. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
    Savvidou S, Hytiroglou P, Orfanou-Koumerkeridou H, Panderis A, Frantzoulis P, Goulis J.
    J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
    [Abstract] [Full Text] [Related]

  • 13. The role of ¹³C-methacetin breath test for the non-invasive evaluation of nonalcoholic fatty liver disease.
    Fierbinteanu-Braticevici C, Plesca DA, Tribus L, Panaitescu E, Braticevici B.
    J Gastrointestin Liver Dis; 2013 Jun; 22(2):149-56. PubMed ID: 23799213
    [Abstract] [Full Text] [Related]

  • 14. The risk factors of fibrosis in nonalcoholic steatohepatitis.
    Fierbinţeanu-Braticevici C, Bengus A, Neamţu M, Usvat R.
    Rom J Intern Med; 2002 Jun; 40(1-4):81-8. PubMed ID: 15526543
    [Abstract] [Full Text] [Related]

  • 15. Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease.
    Machado MV, Gonçalves S, Carepa F, Coutinho J, Costa A, Cortez-Pinto H.
    Liver Int; 2012 Feb; 32(2):241-8. PubMed ID: 22098270
    [Abstract] [Full Text] [Related]

  • 16. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S.
    Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
    Lemoine M, Ratziu V, Kim M, Maachi M, Wendum D, Paye F, Bastard JP, Poupon R, Housset C, Capeau J, Serfaty L.
    Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.